| Name |
Xaviox 14,96 g prašak za oralnu suspenziju u vrećici |
| Marketing Authorisation Number |
HR-H-870909668 |
| Active Substance |
kalcijev polistirensulfonat |
| Composition |
1 vrećica s 15 g praška sadrži 14,96 g kalcijevog polistirensulfonata |
| Pharmaceutical Form |
Prašak za oralnu suspenziju u vrećici |
| Manufacturer |
Laboratorios Rubió, S.A., Castellbisbal, Barcelona, Španjolska |
| Marketing Authorisation Holder |
Makpharm d.o.o., Trnjanska cesta 37/1, Zagreb, Hrvatska |
| Marketing Authorisation Date |
03.09.2021 |
| MA Period of Validity |
03.09.2026 |
| Classification Number |
UP/I-530-09/19-01/54 |
| Registration Number |
381-12-01/154-21-13 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product on medical prescription for renewable delivery
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
V03AE01 |
| Marketing status |
Marketed |
| Shortage status |
No shortage |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
